CSBR - Champions Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
72.62M
Enterprise Value 3
72.12M
Trailing P/E
N/A
Forward P/E 1
44.64
PEG Ratio (5 yr expected) 1
13.89
Price/Sales (ttm)
2.63
Price/Book (mrq)
41.95
Enterprise Value/Revenue 3
2.62
Enterprise Value/EBITDA 6
-465.26

Trading Information

Stock Price History

Beta (3Y Monthly) 2.52
52-Week Change 3-52.15%
S&P500 52-Week Change 38.02%
52 Week High 315.45
52 Week Low 35.07
50-Day Moving Average 35.87
200-Day Moving Average 37.45

Share Statistics

Avg Vol (3 month) 333.86k
Avg Vol (10 day) 316.15k
Shares Outstanding 511.62M
Float 5.77M
% Held by Insiders 120.87%
% Held by Institutions 153.69%
Shares Short (Sep 30, 2019) 4162.92k
Short Ratio (Sep 30, 2019) 43.26
Short % of Float (Sep 30, 2019) 42.50%
Short % of Shares Outstanding (Sep 30, 2019) 41.40%
Shares Short (prior month Aug 30, 2019) 4153.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Aug 12, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr 30, 2019
Most Recent Quarter (mrq)Jul 31, 2019

Profitability

Profit Margin -3.61%
Operating Margin (ttm)-2.99%

Management Effectiveness

Return on Assets (ttm)-4.74%
Return on Equity (ttm)-85.41%

Income Statement

Revenue (ttm)27.58M
Revenue Per Share (ttm)2.40
Quarterly Revenue Growth (yoy)8.20%
Gross Profit (ttm)12.8M
EBITDA -155k
Net Income Avi to Common (ttm)-995k
Diluted EPS (ttm)-0.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.2M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)4.02M
Total Debt/Equity (mrq)232.58
Current Ratio (mrq)0.80
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)1.25M
Levered Free Cash Flow (ttm)63.38k